A. Martinezarends et al., ACTIVATION OF HUMAN TONSIL LYMPHOCYTES BY RABIES VIRUS NUCLEOCAPSID SUPERANTIGEN, Clinical immunology and immunopathology, 77(2), 1995, pp. 177-184
The capacity of the rabies virus superantigen (SAg) and the nucleocaps
id (NC) to activate human tonsil lymphocytes was analyzed by studying
the capacity of NC to cause lymphocytes to proliferate and secrete Ig
and cytokines. NC activation was compared to that obtained with the St
aphylococcus-derived SAg, SEE, and TSST-1. Despite a weak T lymphocyte
mitogenic activity restricted to CD4(+) T cells, NC triggers tonsil B
lymphocytes to produce IgG in quantities and frequencies similar to t
hose of SEE and TSST-1. In the same way as these two SAg, NC induces I
gG production only in the presence of T cells and optimally with a T/B
ratio of 1/5. However, unlike SEE and TSST-1, NC does not trigger IgM
production, The pattern of cytokines produced upon NC activation, IL-
4 and IL-10, weak IL-2 production, and no IFN-gamma, suggests that rab
ies SAg stimulates Th2 rather than Th1 lymphocytes, In contrast, the p
attern of cytokines produced upon TSST-1 activation, IL-2, IFN-gamma,
and no IL-4, suggests that TSST-1 induces rather a Th1 response. The s
pecific Th2 triggering by NC could explain the unique capacity of the
rabies SAg to increase the in vivo antibody response to a simultaneous
ly injected antigen. (C) 1995 Academic Press, Inc.